Home » Topics » Conferences

Conferences
RSS

Lerisetron: a potent, selective, long-acting and orally effective 5-HT3 antagonist

Nov. 12, 1997

PDE IV inhibitor from Almirall does not stimulate gastric acid secretion in rats

Nov. 12, 1997

Amiodarone derivative may be suitable for long-term use

Nov. 12, 1997

New NHE inhibitor (EMD-85131) shows promise for ischemic heart disease

Nov. 12, 1997

Nonpeptide alphav/beta3 antagonist effective in rabbit model of neointima formation

Nov. 12, 1997

Tedisamil demonstrates favorable activity in patients with angina

Nov. 12, 1997

Potent and selective fibrinogen receptor antagonist presented by DuPont Merck

Nov. 12, 1997

C921-78: a new factor Xa antagonist prevents thrombosis with reduced blood loss

Nov. 12, 1997

Preclinical profile of HMR's new KATP channel blocker

Nov. 12, 1997

The selective PDE V inhibitor EMD-82639 shows potential in coronary insufficiency

Nov. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...